Clinical Trial Update: Evaluating Silymarin for Chronic Hepatitis C [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating silymarin for chronic hepatitis C reports that the study is completed; trial results are not included in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Silymarin (silymarin)

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: Hepatitis C, Chronic | Phase 2 | Status: COMPLETED